National Advisory Council on Nurse Education and Practice; Notice of Meeting, 63715-63716 [E8-25568]
Download as PDF
<![CDATA[
Federal Register / Vol. 73, No. 208 / Monday, October 27, 2008 / Notices
ACE, E-mail address:
Karen_T._Matsuoka@omb.eop.gov.
Dated: October 20, 2008.
Janean Chambers,
Reports Clearance Officer.
[FR Doc. E8–25419 Filed 10–24–08; 8:45 am]
BILLING CODE 4184–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2008–N–0038]
Intrapartum Electronic Fetal
Monitoring With Computer Assisted
Diagnosis Workshop—Exploring
Methods of Evaluation
AGENCY:
Food and Drug Administration,
HHS
mstockstill on PROD1PC66 with NOTICES
ACTION:
Notice of public workshop.
The Food and Drug Administration
(FDA) is announcing a public workshop
entitled ‘‘Intrapartum Electronic Fetal
Monitoring (EFM) With Computer
Assisted Diagnosis (CAD)—Exploring
Methods of Evaluation.’’ The objectives
of this workshop are to gather ideas on
how to identify and differentiate
categories of EFM/CAD devices and the
corresponding levels of evidence
needed to validate these devices.
Workshop participants will also discuss
how currently available databases might
be used to verify/validate intrapartum
EFM/CAD algorithms.
Date and Time: The workshop will be
held on November 10, 2008, from 8 a.m.
to 5 p.m. Registrations will be accepted
through October 31, 2008. Participants
are encouraged to arrive early to ensure
time for parking, security screening, and
registration before the meeting. Security
screening will begin at 7 a.m. and
registration will begin at 7:30 a.m. See
Registration Information section of this
document for registration details.
Location: The workshop will be held
at the Food & Drug Administration
White Oak Campus, conference room G–
2047, 10903 New Hampshire Ave.,
Silver Spring, MD 20993.
FDA will make every effort to
accommodate persons with physical
disabilities or special needs. If you
require special accommodations due to
a disability, please notify one of the
contacts listed in this document (see
Contact) at least 7 days in advance of
the workshop.
Contact: Sharon Andrews, Center for
Devices and Radiological Health (HFZ–
470), Food and Drug Administration,
9200 Corporate Blvd., Rockville, MD
20850, 240–276–4148, FAX: 240–276–
4156, sharon.andrews@fda.hhs.gov; or
VerDate Aug<31>2005
17:13 Oct 24, 2008
Jkt 217001
Elaine Blyskun, Center for Devices
and Radiological Health (HFZ–470),
Food and Drug Administration, 9200
Corporate Blvd., Rockville, MD 20850,
240–276–4100, FAX: 240–276–4156,
elaine.blyskun@fda.hhs.gov.
Registration Information: Registration
may be completed online at the
following Web site: https://
www.blsmeetings.net/1368-2. There is
no registration fee for this workshop;
however, all participants must submit a
registration form. Space is limited, so
please register as soon as possible to
reserve a space. Registrations will be
accepted through (see DATES). Persons
without Internet access may contact
Syreeta Tate-Jones at 301–577–0244,
ext. 49 by October 31, 2008, to register.
Agenda: The workshop will begin
with a morning session to provide a
clinical and regulatory overview of
intrapartum fetal monitors. Presentation
topics will address fetal monitoring in
general, the relationship between
technology and clinical decisionmaking,
the current state of EFM/CAD
development, and evaluation/validation
methods that may be applied to new
EFM/CAD systems. In the afternoon,
attendees will break into two discussion
groups: (1) EFM/CAD technological
development and validation and (2) the
practicality of using existing databases
to test new EFM/CAD algorithms. The
workshop will conclude with an
overview of the break-out discussions
and identification of research gaps and
opportunities in the field.
Dated: October 20, 2008.
Jeffrey Shuren,
Associate Commissioner for Policy and
Planning.
[FR Doc. E8–25586 Filed 10–24–08; 8:45 am]
BILLING CODE 4160–01–S
63715
Status: The meeting will be open to the
public.
Purpose: The Advisory Committee
provides advice and recommendations on a
broad range of issues dealing with programs
and activities authorized under section 747
of the Public Health Service Act as amended
by The Health Professions Education
Partnership Act of 1998, Public Law 105–
392. At this meeting the Advisory Committee
will work on its eighth report about the redesign of the delivery of primary health care
and its implications for the training of
primary care practitioners. Reports are
submitted to Congress and to the Secretary of
the Department of Health and Human
Services.
Agenda: The meeting on Monday,
November 17, will begin with opening
comments from the Chair of the Advisory
Committee and introductory remarks from
senior management of the Health Resources
and Services Administration. The Advisory
Committee will elect a new chair and two
vice-chairs prior to the main agenda. In the
plenary session, the Advisory Committee will
discuss key elements they wish to include in
the eighth report, develop an outline for the
report, and draft report recommendations.
The work will be done in plenary session and
in small groups. On Tuesday, November 18,
the Advisory Committee will continue its
work on the eighth report and determine next
steps in the report preparation process. The
members will plan an agenda for the next
Advisory Committee meeting. An
opportunity will be provided for public
comment.
For Further Information Contact: Anyone
interested in obtaining a roster of members or
other relevant information should write or
contact Jerilyn K. Glass, M.D., PhD, Division
of Medicine and Dentistry, Bureau of Health
Professions, Health Resources and Services
Administration, Room 9A–27, Parklawn
Building, 5600 Fishers Lane, Rockville,
Maryland 20857, Telephone (301) 443–6822.
The Web address for information on the
Advisory Committee is https://bhpr.hrsa.gov/
medicine-dentistry/actpcmd.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Health Resources and Services
Administration
Dated: October 21, 2008.
Alexandra Huttinger,
Director, Division of Policy Review and
Coordination.
[FR Doc. E8–25569 Filed 10–24–08; 8:45 am]
BILLING CODE 4165–15–P
Advisory Committee on Training in
Primary Care Medicine and Dentistry;
Notice of Meeting
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Public Law 92–463), notice is hereby
given of the following meeting:
Name: Advisory Committee on Training in
Primary Care Medicine and Dentistry
(ACTPCMD).
Date and Time: November 17, 2008, 8:30
a.m.–4:30 p.m. November 18, 2008, 8 a.m.–
2 p.m.
Place: The Legacy Hotel and Meeting
Centre, 1775 Rockville Pike, Rockville,
Maryland 20852.
PO 00000
Frm 00043
Fmt 4703
Sfmt 4703
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Health Resources and Services
Administration
National Advisory Council on Nurse
Education and Practice; Notice of
Meeting
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Public Law 92–463), notice is hereby
given of the following meeting:
Name: National Advisory Council on
Nurse Education and Practice (NACNEP).
E:\FR\FM\27OCN1.SGM
27OCN1
63716
Federal Register / Vol. 73, No. 208 / Monday, October 27, 2008 / Notices
Dates and Times: November 13, 2008, 8
a.m.–4:30 p.m. November 14, 2008, 8 a.m.–
4:30 p.m.
Place: Bethesda Marriott Suites, 6711
Democracy Boulevard, Rockville, MD 20817.
Status: The meeting will be open to the
public.
Agenda: Agency and Bureau
administrative updates will be provided.
Purpose: The purpose of this meeting will
be to address issues relating to the nursing
faculty shortage and its impact on nurse
education and practice. The objectives of the
meeting are: (1) To analyze achievements
toward meeting recommendations that have
been suggested to address the faculty
shortage put forth in the National Advisory
Council on Nurse Education and Practice:
Second Report to the Secretary of Health and
Human Services and the Congress; (2) to
examine strategies instituted to address the
faculty shortage; (3) to address the academic
preparation of nurse educators; and (4) to
address faculty salaries and any barriers to
increasing faculty salaries.
During this meeting, the NACNEP council
members will deliberate on the content
presented and formulate recommendations to
the Secretary of Health and Human Services
and the Congress on the impact the faculty
shortage is having on nursing education and
practice. Members from professional nursing,
public and private organizations will present
their initiatives on addressing the nursing
faculty shortage. Strategies on how to prepare
nursing faculty for their role will be
presented. This meeting will form the basis
for NACNEP’s mandated Ninth Annual
Report.
For Further Information Contact: Anyone
interested in obtaining a roster of members,
minutes of the meeting, or other relevant
information can contact Nancy DouglasKersellius, Acting Executive Secretary,
National Advisory Council on Nurse
Education and Practice, Parklawn Building,
Room 8C–26, 5600 Fishers Lane, Rockville,
Maryland 20857, telephone (301) 443–5688.
Information can also be found at the
following Web site: https://bhpr.hrsa.gov/
nursing/nacnep.htm.
Dated: October 21, 2008.
Alexandra Huttinger,
Director, Division of Policy Review and
Coordination.
[FR Doc. E8–25568 Filed 10–24–08; 8:45 am]
BILLING CODE 4165–15–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
mstockstill on PROD1PC66 with NOTICES
Government-Owned Inventions;
Availability for Licensing
National Institutes of Health,
Public Health Service, HHS.
ACTION: Notice.
AGENCY:
SUMMARY: The inventions listed below
are owned by an agency of the U.S.
Government and are available for
VerDate Aug<31>2005
17:13 Oct 24, 2008
Jkt 217001
licensing in the U.S. in accordance with
35 U.S.C. 207 to achieve expeditious
commercialization of results of
federally-funded research and
development. Foreign patent
applications are filed on selected
inventions to extend market coverage
for companies and may also be available
for licensing.
ADDRESSES: Licensing information and
copies of the U.S. patent applications
listed below may be obtained by writing
to the indicated licensing contact at the
Office of Technology Transfer, National
Institutes of Health, 6011 Executive
Boulevard, Suite 325, Rockville,
Maryland 20852–3804; telephone: 301/
496–7057; fax: 301/402–0220. A signed
Confidential Disclosure Agreement will
be required to receive copies of the
patent applications.
Method of Treating and Preventing
Infections in Immunocompromised
Subjects With Immunostimulatory CpG
Oligonucleotides
Description of Technology: Primary
disorders of the immune system can be
divided into four categories, (1)
disorders of the humoral immunity, (2)
disorders of cellular immunity, (3)
disorders of phagocytes, and (4)
disorders of complement. In addition,
there are many causes of secondary
immunodeficiency such as treatment
with immunosuppressive or
chemotherapeutic agents, protein-losing
enteropathy, and infection with a
human immunodeficiency virus (HIV).
Generally, immunocompromised
patients are unable to mount an immune
response to a vaccine or an infection in
the same manner as nonimmunocompromised individuals.
Opportunistic infections to which
individuals infected with HIV are
susceptible include bacterial infections
such as salmonellosis, syphilis and
neurosyphilis, tuberculosis (TB), a
typical mycobacterial infection, and
bacillary angiomatosis (cat scratch
disease), fungal infections such as
aspergillosis, candidiasis (thrush, yeast
infection), coccidioidomycosis,
cryptococcal meningitis, and
histoplasmosis, protozoal infections
such as cryptosporidiosis, isosporiasis,
microsporidiosis, Pneumocystis Carinii
pneumonia (PCP), and toxoplasmosis,
viral infections such as Cytomegalovirus
(CMV), hepatitis, herpes simplex (HSV,
genital herpes), herpes zoster (HZV,
shingles), human papilloma virus (HPV,
genital warts, cervical cancer),
Molluscum Contagiosum, oral hairy
leukoplakia (OHL), and progressive
multifocal leukoencephalopathy (PML),
and neoplasms such as Kaposi’s
PO 00000
Frm 00044
Fmt 4703
Sfmt 4703
sarcoma, systemic non-Hodgkin’s
lymphoma (NHL), and primary CNS
lymphoma, among others. These
opportunistic infections remain
principally responsible for the
morbidity and mortality associated with
HIV disease.
This application claims use of
immunostimulatory D-type CpG
oligonucleotides for the treatment of
immunocompromised individuals. More
specifically, the application claims use
of immunostimulatory D-type CpG
oligonucleotides for the treatment of
individuals infected with HIV.
Application: Vaccine adjuvants,
production of vaccines,
immunotherapeutics.
Development Status: Preclinical
studies have been performed;
oligonucleotides have been synthesized.
Inventors: Dennis Klinman (FDA/
CBER; NCI) and Daniela Verthelyi
(FDA/CBER).
Patent Status: U.S. Provisional
Application No. 60/411,944 filed 18 Sep
2002 (HHS Reference No. E–153–2002/
0–US–01); U.S. Patent Application No.
10/666,022 filed 17 Sep 2003 (HHS
Reference No. E–153–2002/0–US–03).
Licensing Status: Available for
exclusive or nonexclusive licensing.
Licensing Contact: Peter A. Soukas,
J.D.; 301–435–4646;
soukasp@mail.nih.gov.
Collaborative Research Opportunity:
The National Cancer Institute,
Laboratory of Experimental
Immunology, Immune Modulation
Group, is seeking statements of
capability or interest from parties
interested in collaborative research to
further develop, evaluate, or
commercialize this technology. Please
contact John D. Hewes, PhD at 301–435–
3121 or hewesj@mail.nih.gov for more
information.
Method of Treating Infectious and
Inflammatory Lung Disease With
Suppressive Oligonucleotides
Description of Technology: Lung
disease is the number three killer in
America, responsible for one in seven
deaths, and lung disease and other
breathing problems are the number one
killer of babies younger than one year
old. Today, more than thirty (30)
million Americans are living with
chronic inflammatory lung diseases
such as emphysema and chronic
bronchitis. In addition, approximately
one hundred and fifty thousand
(150,000) Americans are affected by
acute respiratory distress syndrome
(ARDS) each year.
Many lung diseases are associated
with lung inflammation. For example,
ARDS involves the rapid onset of
E:\FR\FM\27OCN1.SGM
27OCN1
]]>Agencies
[Federal Register Volume 73, Number 208 (Monday, October 27, 2008)]
[Notices]
[Pages 63715-63716]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E8-25568]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Health Resources and Services Administration
National Advisory Council on Nurse Education and Practice; Notice
of Meeting
In accordance with section 10(a)(2) of the Federal Advisory
Committee Act (Public Law 92-463), notice is hereby given of the
following meeting:
Name: National Advisory Council on Nurse Education and Practice
(NACNEP).
[[Page 63716]]
Dates and Times: November 13, 2008, 8 a.m.-4:30 p.m. November
14, 2008, 8 a.m.-4:30 p.m.
Place: Bethesda Marriott Suites, 6711 Democracy Boulevard,
Rockville, MD 20817.
Status: The meeting will be open to the public.
Agenda: Agency and Bureau administrative updates will be
provided.
Purpose: The purpose of this meeting will be to address issues
relating to the nursing faculty shortage and its impact on nurse
education and practice. The objectives of the meeting are: (1) To
analyze achievements toward meeting recommendations that have been
suggested to address the faculty shortage put forth in the National
Advisory Council on Nurse Education and Practice: Second Report to
the Secretary of Health and Human Services and the Congress; (2) to
examine strategies instituted to address the faculty shortage; (3)
to address the academic preparation of nurse educators; and (4) to
address faculty salaries and any barriers to increasing faculty
salaries.
During this meeting, the NACNEP council members will deliberate
on the content presented and formulate recommendations to the
Secretary of Health and Human Services and the Congress on the
impact the faculty shortage is having on nursing education and
practice. Members from professional nursing, public and private
organizations will present their initiatives on addressing the
nursing faculty shortage. Strategies on how to prepare nursing
faculty for their role will be presented. This meeting will form the
basis for NACNEP's mandated Ninth Annual Report.
For Further Information Contact: Anyone interested in obtaining
a roster of members, minutes of the meeting, or other relevant
information can contact Nancy Douglas-Kersellius, Acting Executive
Secretary, National Advisory Council on Nurse Education and
Practice, Parklawn Building, Room 8C-26, 5600 Fishers Lane,
Rockville, Maryland 20857, telephone (301) 443-5688. Information can
also be found at the following Web site: https://bhpr.hrsa.gov/
nursing/nacnep.htm.
Dated: October 21, 2008.
Alexandra Huttinger,
Director, Division of Policy Review and Coordination.
[FR Doc. E8-25568 Filed 10-24-08; 8:45 am]
BILLING CODE 4165-15-P
